Sanofi and GlaxoSmithKline have reported promising results from trials of their Covid-19 vaccine, which has proved to be particularly effective against the Omicron strain of coronavirus.
赛诺菲(Sanofi)和葛兰素史克(GlaxoSmithKline)报告了其新冠疫苗令人鼓舞的试验结果，该疫苗被证明对新冠病毒Omicron毒株特别有效。
您已阅读13%（264字），剩余87%（1782字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。